Thermo Fisher Scientific Inc. (TMO) Revenue by Segment

Thermo Fisher Scientific revenue by segment at a glance

In Q2 fiscal 2026 (the quarter ended June 27, 2026), Thermo Fisher Scientific's largest business segment was Laboratory Products and Biopharma Services, with $6.65 billion or 55% of revenue, up 11.7% from a year earlier. Next: Life Sciences Solutions (20%), Analytical Instruments (15%) and Specialty Diagnostics (10%).

By product or service, Service brought in 43%, Product, Consumables brought in 42% and Product, Instruments brought in 15% of revenue in Q2 fiscal 2026.

By region, North America brought in 51%, Europe brought in 28% and Asia Pacific brought in 18% of revenue in Q2 fiscal 2026.

The fastest-growing business segment from a year earlier was Laboratory Products and Biopharma Services (+11.7%).

From company filings, in USD; latest quarter ended June 27, 2026; quarterly data from Q3 fiscal 2017.

Thermo Fisher Scientific Inc.

TMOHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Laboratory Products and ServicesLife Sciences SolutionsAnalytical InstrumentsLaboratory Products and Biopharma ServicesSpecialty Diagnostics

Q2 FY26 breakdown

Fiscal quarter ended Jun 27, 2026

Item	Revenue	Share	vs year before
Laboratory Products and Biopharma Services	USD 6.65B	55.5%	+11.7%
Life Sciences Solutions	USD 2.35B	19.6%	+11.3%
Analytical Instruments	USD 1.80B	15.0%	+7.8%
Specialty Diagnostics	USD 1.19B	9.9%	+6.3%

Sum of items USD 11.99B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18	Q4 FY17	Q3 FY17
Laboratory Products and Services	–	–	–	–	–	–	–	–	–	5.7B	5.7B	5.7B	5.8B	5.8B	5.9B	5.6B	5.5B	5.4B	4.2B	3.5B	3.6B	3.6B	3.6B	3.1B	2.8B	2.7B	2.8B	2.6B	2.6B	2.5B	2.6B	2.5B	2.5B	2.4B	–	1.9B
Life Sciences Solutions	2.4B	2.2B	2.5B	2.2B	2.1B	2.0B	2.6B	2.0B	2.0B	1.9B	2.5B	2.4B	2.5B	2.6B	3.0B	3.0B	3.3B	4.2B	4.2B	3.7B	3.6B	4.2B	4.4B	3.4B	2.6B	1.8B	1.8B	1.7B	1.7B	1.6B	1.7B	1.5B	1.6B	1.5B	–	1.4B
Analytical Instruments	1.8B	1.7B	2.2B	1.8B	1.7B	1.7B	2.2B	1.8B	1.7B	1.6B	2.0B	1.8B	1.7B	1.7B	1.9B	1.6B	1.6B	1.5B	1.7B	1.5B	1.5B	1.4B	1.6B	1.3B	1.1B	1.1B	1.5B	1.4B	1.3B	1.3B	1.6B	1.3B	1.3B	1.3B	–	1.2B
Laboratory Products and Biopharma Services	6.7B	6.0B	6.3B	5.9B	6.0B	5.6B	6.2B	5.7B	5.7B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Specialty Diagnostics	1.2B	1.1B	1.2B	1.2B	1.1B	1.1B	1.2B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.5B	1.4B	1.4B	1.2B	1.6B	2.0B	1.4B	988.0M	958.0M	939.0M	879.0M	943.0M	957.0M	951.0M	894.0M	932.0M	947.0M	–	844.0M

Thermo Fisher Scientific revenue by business segment, last 4 quarters

Business segment	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Laboratory Products and Biopharma Services	$6.7B	$6.0B	$5.9B	$6.0B	55%
Life Sciences Solutions	$2.4B	$2.2B	$2.2B	$2.1B	20%
Analytical Instruments	$1.8B	$1.7B	$1.8B	$1.7B	15%
Specialty Diagnostics	$1.2B	$1.1B	$1.2B	$1.1B	10%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Thermo Fisher Scientific revenue by product or service, last 4 quarters

Product or service	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Service	$5.2B	$4.7B	$4.6B	$4.6B	43%
Product, Consumables	$5.1B	–	–	$4.6B	42%
Product, Instruments	$1.8B	–	–	$1.6B	15%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Thermo Fisher Scientific revenue by region, last 4 quarters

Region	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
North America	$6.1B	$5.7B	$5.7B	$5.7B	51%
Europe	$3.3B	$3.0B	$3.0B	$2.8B	28%
Asia Pacific	$2.1B	$2.0B	$2.0B	$1.9B	18%
Other Regions	$430.0M	$372.0M	$415.0M	$383.0M	4%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Questions and answers

What are Thermo Fisher Scientific's business segments?

Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments and Specialty Diagnostics (as reported for Q2 fiscal 2026).

Which business segment makes the most money for Thermo Fisher Scientific?

Laboratory Products and Biopharma Services: $6.65 billion, or 55% of revenue, in Q2 fiscal 2026.

What are Thermo Fisher Scientific's main products and services?

By revenue in Q2 fiscal 2026: Service (43%), Product, Consumables (42%) and Product, Instruments (15%).

Where does Thermo Fisher Scientific make its money?

By region in Q2 fiscal 2026: North America (51%), Europe (28%), Asia Pacific (18%) and Other Regions (4%).

MoreThermo Fisher Scientific stock overview Thermo Fisher Scientific financials Thermo Fisher Scientific executive team Thermo Fisher Scientific shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Laboratory Products and ServicesLife Sciences SolutionsAnalytical InstrumentsLaboratory Products and Biopharma ServicesSpecialty Diagnostics

Q2 FY26 breakdown

Fiscal quarter ended Jun 27, 2026

Item	Revenue	Share	vs year before
Laboratory Products and Biopharma Services	USD 6.65B	55.5%	+11.7%
Life Sciences Solutions	USD 2.35B	19.6%	+11.3%
Analytical Instruments	USD 1.80B	15.0%	+7.8%
Specialty Diagnostics	USD 1.19B	9.9%	+6.3%

Sum of items USD 11.99B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18	Q4 FY17	Q3 FY17
Laboratory Products and Services	–	–	–	–	–	–	–	–	–	5.7B	5.7B	5.7B	5.8B	5.8B	5.9B	5.6B	5.5B	5.4B	4.2B	3.5B	3.6B	3.6B	3.6B	3.1B	2.8B	2.7B	2.8B	2.6B	2.6B	2.5B	2.6B	2.5B	2.5B	2.4B	–	1.9B
Life Sciences Solutions	2.4B	2.2B	2.5B	2.2B	2.1B	2.0B	2.6B	2.0B	2.0B	1.9B	2.5B	2.4B	2.5B	2.6B	3.0B	3.0B	3.3B	4.2B	4.2B	3.7B	3.6B	4.2B	4.4B	3.4B	2.6B	1.8B	1.8B	1.7B	1.7B	1.6B	1.7B	1.5B	1.6B	1.5B	–	1.4B
Analytical Instruments	1.8B	1.7B	2.2B	1.8B	1.7B	1.7B	2.2B	1.8B	1.7B	1.6B	2.0B	1.8B	1.7B	1.7B	1.9B	1.6B	1.6B	1.5B	1.7B	1.5B	1.5B	1.4B	1.6B	1.3B	1.1B	1.1B	1.5B	1.4B	1.3B	1.3B	1.6B	1.3B	1.3B	1.3B	–	1.2B
Laboratory Products and Biopharma Services	6.7B	6.0B	6.3B	5.9B	6.0B	5.6B	6.2B	5.7B	5.7B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Specialty Diagnostics	1.2B	1.1B	1.2B	1.2B	1.1B	1.1B	1.2B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.5B	1.4B	1.4B	1.2B	1.6B	2.0B	1.4B	988.0M	958.0M	939.0M	879.0M	943.0M	957.0M	951.0M	894.0M	932.0M	947.0M	–	844.0M